Indication:Prohylaxis of episodic and chronic migraine
Galcanezumab is recommended for prophylaxis of episodic and chronic migraine, only if at least 3 preventive drug treatments have failed. Treatment should be stopped after 12 weeks if the headache frequency does not reduce by 50% with episodic, and 30% with chronic migraine. The drug must be prescribed by brand. Patient’s once trained to give subcutaneous can self-administer.